Aptus Biotech is a biotech start-up founded in 2010 with a focus on pioneering new biotechnological applications based on aptamers. The company's collaboration with the Ramon y Cajal Hospital Foundation and other research centers has enabled the development of innovative therapeutic and diagnostic tools using aptamer technology. Aptus Biotech offers a range of services including aptamer selection, storage, chemical synthesis, and binding studies with target proteins. Their utilization of aptamers, oligonucleotides capable of identifying target molecules with high affinity and specificity, positions them as a promising player in the biotechnology and healthcare industries. With headquarters in Spain, Aptus Biotech's expertise, extensive research experience, and strategic partnerships provide a strong foundation for future growth and impact in the biotech sector.
There is no investment information
No recent news or press coverage available for Aptus Biotech.